Clinical and Molecular Hepatology

Discordant FIB-4 and liver stiffness in metabolic dysfunction-associated steatotic liver disease as related to histology and liver-related events in a global cohort: Editorial on “Histological severity and hepatic outcomes in patients with metabolic dysfunction-associated steatotic liver disease and discrepant FIB-4 and liver stiffness measurement”: Gurmehr Brar, Brian P. Lee; Clin Mol Hepatol 2026;32(3):1409-1412.
Published online January 9, 2026; DOI: https://doi.org/10.3350/cmh.2025.1484

Citations

Citations to this article as recorded by

Nutritional-inflammatory indices optimize the diagnostic performance of FIB-4 for advanced fibrosis/cirrhosis in patients with benign liver disease
Jing Zhou, Daofeng Yang, Jun Lu
Annals of Medicine.2026;[Epub] CrossRef
Psychometric profiles and the phenotypic dissociation of imaging steatosis and elevated fibrosis risk in obesity
Nuryil Yilmaz, Enis Akca, Zeynep Ekinci, Melik Firat Fidan, Zeynep Pekel, Zelihan Kafadar, Barkin Yigitbasi, Huseyin Dongelli, Metin Ozgen, Demet Yalcin Kehribar
Current Medical Research and Opinion.2026; : 1. CrossRef

Letter to the editor on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”: Chunyan Wang, Jun Sun, Yinyan Li; Clin Mol Hepatol 2026;32(2):e146-e148.
Published online June 9, 2025; DOI: https://doi.org/10.3350/cmh.2025.0539

Citations

Citations to this article as recorded by

Correspondence to letter to the editor on “Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease”
Hye Won Lee, Seung Up Kim
Clinical and Molecular Hepatology.2026; 32(2): e244. CrossRef

Reply to correspondence on “Current burden of steatotic liver disease and fibrosis among adults in the United States, 2017-2023”: Jeayeon Park, Su Jong Yu; Clin Mol Hepatol 2025;31(2):e221-e223.
Published online March 4, 2025; DOI: https://doi.org/10.3350/cmh.2025.0226

Reply to correspondence on “Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using vibration-controlled transient elastography: Systematic review and meta-analysis”: Mirko Zoncapè, Emmanuel A. Tsochatzis; Clin Mol Hepatol 2025;31(1):e117-e118.
Published online November 11, 2024; DOI: https://doi.org/10.3350/cmh.2024.0994

The independent effect of exercise on biopsy proven non-alcoholic fatty liver disease: A systematic review: Young-Joo Jin; Clin Mol Hepatol 2023;29(2):414-416.
Published online February 28, 2023; DOI: https://doi.org/10.3350/cmh.2023.0055

Citations

Citations to this article as recorded by

Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies
Hee-Tae Roh, Ju-Yong Bae
Medicina.2026; 62(4): 784. CrossRef
The impact of resistance training in patients diagnosed with metabolic dysfunction-associated steatotic liver disease: a systematic review
Daniele Gorski Medeiros, Luis Fernando Ferreira, Jessica da Silva Lamp, Luis Henrique Telles da Rosa
European Journal of Gastroenterology & Hepatology.2025; 37(2): 129. CrossRef